BG Medicine Posts 7 Percent Rise in Q4 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) – BG Medicine today reported a 7 percent increase year over year in revenues for the fourth quarter.

The Waltham, Mass.-based firm said that revenues for the three months ended Dec. 31, 2013 totaled $1.15 million, up from $1.07 million a year ago and beating the average analyst estimate of $1.1 million. Product revenues, however, declined to $884,000 from $978,000 a year ago, a 10 percent drop. Service revenues were up 182 percent to $265,000 from $94,000 in Q4 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.